Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes (TEACH-PD)
TEACH-PD Update - A Targeted Education Approach to improve Peritoneal Dialysis Outcomes (TEACH-PD)
Co-Principal Investigator: Professor Josephine Chow & Professor Neil Boudville
Lead, THN Healthcare Professional Education Group: Melinda Tomlins
TEACH-PD CRCT commenced in Australia in September 2019 and New Zealand in February 2020
Co-Principal Investigator: Professor Josephine Chow & Professor Neil Boudville
Lead, THN Healthcare Professional Education Group: Melinda Tomlins
TEACH-PD CRCT commenced in Australia in September 2019 and New Zealand in February 2020
A pragmatic, multi-centre, multinational, registry-based, cluster-randomised trial (CRCT), randomising PD units to implementing TEACH-PD training modules targeted at PD trainers and incident PD patients versus standard existing practices.
The TEACH-PD training curriculum and material have been developed by a core group of renal nurses from the HOME Network (THN) in conjunction with senior medical clinicians from the Australasian Kidney Trials Network (AKTN), eLearning curriculum developers, consumer representatives, and education experts, in line with the ISPD guidelines, utilising modern adult learning principles and best practice eLearning techniques. The trial is integrated into usual clinical practice and no face-to-face study visits are required, follow-up of the enrolled participants is unlikely to be affected by the COVID-19 pandemic.
The TEACH-PD training curriculum and material have been developed by a core group of renal nurses from the HOME Network (THN) in conjunction with senior medical clinicians from the Australasian Kidney Trials Network (AKTN), eLearning curriculum developers, consumer representatives, and education experts, in line with the ISPD guidelines, utilising modern adult learning principles and best practice eLearning techniques. The trial is integrated into usual clinical practice and no face-to-face study visits are required, follow-up of the enrolled participants is unlikely to be affected by the COVID-19 pandemic.
